Discovery and systematic assessment of early biomarkers that predict progression to severe COVID-19 disease

BACKGROUND: The clinical course of COVID-19 patients ranges from asymptomatic infection, via mild and moderate illness, to severe disease and even fatal outcome. Biomarkers which enable an early prediction of the severity of COVID-19 progression, would be enormously beneficial to guide patient care...

Descripción completa

Detalles Bibliográficos
Autores principales: Hufnagel, Katrin, Fathi, Anahita, Stroh, Nadine, Klein, Marco, Skwirblies, Florian, Girgis, Ramy, Dahlke, Christine, Hoheisel, Jörg D., Lowy, Camille, Schmidt, Ronny, Griesbeck, Anne, Merle, Uta, Addo, Marylyn M., Schröder, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089829/
https://www.ncbi.nlm.nih.gov/pubmed/37041310
http://dx.doi.org/10.1038/s43856-023-00283-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089829/
https://www.ncbi.nlm.nih.gov/pubmed/37041310
http://dx.doi.org/10.1038/s43856-023-00283-z

Ejemplares similares